BRAF Mutant Colorectal Cancer: ErbB2 Expression Levels as Predictive Factor for the Response to Combined BRAF/ErbB Inhibitors
BMC Cancer - United Kingdom
doi 10.1186/s12885-020-6586-0
Full Text
Open PDFAbstract
Available in full text
Date
February 17, 2020
Authors
Publisher
Springer Science and Business Media LLC